Volume 10, Issue 4 (winter 2014)
Sci J Iran Blood Transfus Organ 2014, 10(4): 347-352 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Samadi M, Ghasemzade A, Sarizade G, Ebrahimi S, Saati S, Abassinejad-Pour A et al . The comparison of the prevalence rates of HBV, HCV, and HIV in blood donors having deferred for high risk behaviors . Sci J Iran Blood Transfus Organ 2014; 10 (4) :347-352
URL: http://bloodjournal.ir/article-1-826-en.html
URL: http://bloodjournal.ir/article-1-826-en.html
M. Samadi * 
, A.H. Ghasemzade , Gh. Sarizade , S. Ebrahimi , Sh. Saati , A. Abassinejad-Pour , L. Nazar Ardekani
, A.H. Ghasemzade , Gh. Sarizade , S. Ebrahimi , Sh. Saati , A. Abassinejad-Pour , L. Nazar Ardekani
Abstract: (9938 Views)
Abstract
Background and Objectives
Selection of healthy blood donors is an important process to identify high risk volunteers. Monitoring and evaluation of the deferral procedure is of the highest importance to balance blood availability and safety. The aim of the current study was to compare the prevalence of HBV, HCV and HIV serologic markers between deferred donors and eligible blood donors to assess the value of the current donor selection process.
Materials and Methods
Six hundred and nineteen voluntary blood donors in Ahvaz city were included. Serum samples from deferred and eligible donors were examined for serologic markers of HBV, HCV, and HIV using enzyme-linked immunosorbent assay. All positive samples were confirmed using confirmatory tests.
Results
The prevalence rates of HBV infection among deferred and eligible blood donors were estimated to be 0.5% and 0.2%, respectively. Anti-HCV reactivity was detected among 1.3% of deferred blood donors. Moreover, the prevalence of anti-HIV among deferred and eligible blood donors was 0.2% and 0.05%, respectively. We found that the overall prevalence rates of HBsAg, anti-HCV, and anti-HIV in the deferred blood donors are significantly higher than those in the eligible blood donors.
Conclusions
The results of this study indicate the high prevalence rate of blood borne infections. Moreover, it seems that the current donor selection process is effective to identify healthy blood donors. However, the effectiveness of some of the currently used deferral questions in reducing viral risks warrants further study.
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
